K203827 is an FDA 510(k) clearance for the REMI. This device is classified as a Reduced- Montage Standard Electroencephalograph (Class II - Special Controls, product code OMC).
Submitted by Epitel, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on March 29, 2021, 90 days after receiving the submission on December 29, 2020.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A User-specified And/or Sponsor-specified Locations With A Reduced Array (i.e. Less Than < 16) Of Electrodes.